The Luhe Teaching Hospital of the Capital Medical University
12
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
2 terminated/withdrawn out of 12 trials
33.3%
-53.2% vs industry average
25%
3 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy
Role: collaborator
Feasibility and Preliminary Efficacy of a Theory-driven BALANCE Dietary Program Among Patients With Type 2 Diabetes
Role: collaborator
Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN
Role: collaborator
Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome
Role: collaborator
Preliminary Effect of a Health Information Literacy Enhancement Program for Individuals With Metabolic Syndrome
Role: collaborator
The Study of Efficacy and Safety of Automated PD in Urgent Start Dialysis
Role: collaborator
Study of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Patients With Abdominal Distension
Role: collaborator
Results of Endovascular Treatment for Infrapopliteal Arterial Occlusive Disease.
Role: collaborator
Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
Role: collaborator
Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)
Role: collaborator
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
Role: collaborator
Intensive Education on Lipid Management
Role: collaborator
All 12 trials loaded